In patients who underwent PET/CT and complete resection for clinical stage IA lung adenocarcinoma, maximum standardized uptake value was an independent predictor of grade 3 lung adenocarcinoma and helped identify high-risk patients treated with segmentectomy or limited nodal dissection.
The Dense Tissue and Early Breast Neoplasm Screening-2 (DENSE-2) trial addresses whether supplemental contrast-enhanced mammography and abbreviated MRI can lead to fewer interval cancers in women with extremely dense breasts compared with mammography.
